Status:
COMPLETED
Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia
Lead Sponsor:
Albert Einstein Healthcare Network
Conditions:
Hypoglycemia
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
Background: Hypoglycemia is a common presentation to the Emergency Department. Management has traditionally involved rapid administration of IV 50% dextrose and dextrose containing IV fluids in addit...
Detailed Description
Methods: All adult (\>18 years old) non-pregnant patients presenting to the Emergency Department with hypoglycemia (serum glucose \< 60 mg/dl) will be identified and screened for inclusion by the ED ...
Eligibility Criteria
Inclusion
- Hypoglycemia (serum glucose \< 60mg/dl) and concurrent use of a sulfonylurea.
Exclusion
- Age \<18. Pregnancy. Inability to provide informed consent.
Key Trial Info
Start Date :
June 1 2005
Trial Type :
INTERVENTIONAL
End Date :
January 1 2007
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00804297
Start Date
June 1 2005
End Date
January 1 2007
Last Update
December 8 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Albert Einstein Medical Center
Philadelphia, Pennsylvania, United States, 19141